Download helpful SKYCLARYS resources

Patients featured are paid spokespersons for Biogen.

SKYCLARYS patient resources

To help support you along each step of your journey with Friedreich ataxia (FA), we've compiled several resources and links you may find useful. If you have any further questions about FA or treatment with SKYCLARYS, talk with your doctor or contact Biogen REACH.

SKYCLARYS resources for you throughout
your treatment

Patient Brochure

Download information about FA and SKYCLARYS

Download
Understanding Treatment Brochure

Explore information to help you get ready for treatment with SKYCLARYS

Download
SKYCLARYS Dosing Tracker

Keep track of your SKYCLARYS refills and quickly access contact information for your SKYCLARYS support team

Download
SKYCLARYS FAQs

Find answers to frequently asked questions about SKYCLARYS

Download
SKYCLARYS Doctor Discussion Guide

Review this guidance on how to facilitate conversations with your doctor around FA and SKYCLARYS

Download

Support for accessing SKYCLARYS with
Biogen REACH

REACH Brochure

Discover Biogen REACH support resources for SKYCLARYS

Download
Biogen REACH Start Form

Bring this form to your doctor to register for Biogen REACH program support services

Download
Folleto para el paciente

Descargar información sobre FA y SKYCLARYS

Descargar
Folleto para comprender el tratamiento

Explore la información que lo ayudará a prepararse para el tratamiento con SKYCLARYS.

Descargar
NEXT: Biogen REACH

INDICATION AND IMPORTANT SAFETY INFORMATION

WHAT IS SKYCLARYS?

  • SKYCLARYS® (omaveloxolone) is used for the treatment of Friedreich ataxia in adults and children aged 16 years and older. It is not known if SKYCLARYS is safe and effective for use in children younger than 16 years of age

IMPORTANT SAFETY INFORMATION

What are the possible side effects of SKYCLARYS?

SKYCLARYS may cause serious side effects, including:

  • Increase in blood liver enzymes: Some people taking SKYCLARYS have had an increase in the level of liver enzymes in their blood. Your healthcare provider will do liver function tests
    • before you start taking SKYCLARYS
    • every month for the first 3 months after starting your treatment with SKYCLARYS
    • during certain times as needed while taking SKYCLARYS

If your liver enzymes increase, your healthcare provider may change your dose, stop treatment for some time, or completely stop treatment with SKYCLARYS.

  • Increase in a blood protein called B-Type Natriuretic Peptide (BNP). BNP tells how well your heart is working. Your healthcare provider will check your BNP levels before your treatment with SKYCLARYS. Tell your healthcare provider if you have signs and symptoms of your heart not working well such as too much fluid in your body (fluid overload). Signs and symptoms may include:
    • sudden weight gain (3 pounds or more of weight gain in 1 day, or 5 pounds or more of weight gain in 1 week)
    • swelling in your arms, hands, legs, or feet (peripheral edema)
    • fast heartbeat (palpitations)
    • shortness of breath

If you have symptoms of fluid overload that is considered a side effect of SKYCLARYS, your healthcare provider may stop treatment with SKYCLARYS.

  • Changes in cholesterol levels. Increases in low density lipoprotein cholesterol (LDL-C) or bad cholesterol and decreases in high density lipoprotein cholesterol (HDL-C) or good cholesterol have happened during treatment with SKYCLARYS. Your healthcare provider will check your cholesterol levels before and during your treatment with SKYCLARYS

The most common side effects of SKYCLARYS include: increased liver enzymes (ALT/AST), headache, nausea, stomach pain, tiredness, diarrhea, and muscle pain.

Before taking SKYCLARYS, tell your healthcare provider about all of your medical conditions, including if you:

  • have liver problems
  • have a history of heart problems, including heart failure
  • have a high level of fat in your blood (high blood cholesterol)
  • are pregnant or plan to become pregnant. It is not known if SKYCLARYS will harm your unborn baby. Women who use hormonal birth control should use another form of birth control such as a non-hormonal intrauterine system or an extra non-hormonal birth control such as condoms while using SKYCLARYS and for 28 days after stopping SKYCLARYS
  • Pregnancy exposure registry: There is a pregnancy registry for women who are pregnant and are taking SKYCLARYS. The purpose of this registry is to collect information about the health of you and your baby. Your healthcare provider can enroll you or you may enroll yourself by calling 1⁠-866⁠-609-⁠1785 or by sending an email to SkyclarysPregnancySurveillance@ppd.com
  • are breastfeeding or plan to breastfeed. It is not known if SKYCLARYS passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take SKYCLARYS

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements such as St. John’s Wort.

  • Taking SKYCLARYS with other medicines can cause serious side effects
  • SKYCLARYS may affect the way other medicines work, and other medicines may affect how SKYCLARYS works
  • Know the medicines you take. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine

What should I avoid while taking SKYCLARYS?

  • Do not drink grapefruit juice or eat grapefruit. These may change the amount of SKYCLARYS in your blood

These are not all the possible side effects of SKYCLARYS. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1⁠-800⁠-FDA⁠-⁠1088.

Please see full Prescribing Information, including Patient Information.

 

Intended for a US audience.

©2026 Biogen. All rights reserved.
SKY-US-0872v3 05/26